Clinical Trial Update: Sunitinib Maintenance Therapy After Induction Platinum-Based Chemotherapy in Patients With ES-SCLC [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating maintenance therapy with sunitinib after induction platinum-based chemotherapy in extensive-stage small cell lung cancer has completed …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Extensive-stage Small Cell Lung Cancer

Drugs mentioned

• Sutent (sunitinib)

Snippet

Sponsor: University of Michigan Rogel Cancer Center | Conditions: Extensive-Stage Small Cell Lung Cancer | Phase 2 | Status: COMPLETED | Results posted: 2014-04-21